5-fluorouracilo tópico en el tratamiento de la neoplasia intraepitelial vaginal / Topical 5-fluorouracil for treatment of vaginal intraepithelial neoplasms
Ginecol. obstet. Méx
;
70(5): 244-247, mayo 2002.
Artículo
en Español
| LILACS
| ID: lil-331092
RESUMO
OBJECTIVE:
Our purpose was to determine the effectiveness of 5-fluorouracil (5-FU) in the treatment of vaginal intraepithelial neoplasia (VAIN). MATERIALS ANDMETHODS:
The study was performed in 30 patients with a mean age of 54 years and previous diagnoses from reviewed records and histopathology slides selected from a group of 65 patients with VAIN from 1980 to 1998. Patients received intravaginal treatment with 5-FU, 1.5 g once weekly for 10 weeks and all patients were followed up for at least 2-years. Papanicolaou smear and colposcopy were performed, as was biopsy when indicated.RESULTS:
Twenty eight (93) patients with VAIN had prior or concurrent anogenital squamous neoplasia, including 5 with invasive cervical carcinoma and 23 with cervical intraepithelial neoplasia. In 23 of 30 treated patients (77), VAIN went into remission after a single treatment; in 3, (10), it went into remission after two treatment; 3 (10) had recurrent VAIN 3; and in 1 (3) it progressed to invasive vaginal cancer. The treatment was well tolerated.CONCLUSIONS:
The 5-FU is an option choice for VAIN treatment. It is effective, with minimal slide effects. Its use should be confined to treating extensive or multifocal high-grade VAIN.
Buscar en Google
Índice:
LILACS (Américas)
Asunto principal:
Neoplasias Vaginales
/
Displasia del Cuello del Útero
/
Fluorouracilo
/
Antimetabolitos Antineoplásicos
Límite:
Adulto
/
Aged80
/
Femenino
/
Humanos
Idioma:
Español
Revista:
Ginecol. obstet. Méx
Asunto de la revista:
Ginecologia
/
Obstetrícia
Año:
2002
Tipo del documento:
Artículo
País de afiliación:
México
Institución/País de afiliación:
Instituto Mexicano del Seguro Social/MX
Similares
MEDLINE
...
LILACS
LIS